Patient presents with a biopsy-proven basal cell carcinoma (BCC). Physician uses a punch instrument to excise the lesion. Should this be coded as an excision (code 116xx) based on lesion size and anatomic location or punch biopsy (code 11104 )? ...
Subscribe or sign in to view the full article.
Article Overview
This short coding guidance article addresses how to think about a skin lesion procedure involving a previously diagnosed basal cell carcinoma and a punch instrument. It is aimed at medical coders and billing staff who need to distinguish between procedure intent, biopsy reporting, and lesion excision reporting for dermatology-related services. The discussion focuses on general documentation concepts and selection between broad code families for skin biopsy and malignant lesion excision.
Why This Topic Matters
Correctly classifying skin procedures affects accurate claim reporting and compliance. This topic is especially relevant when prior diagnostic workup and later definitive removal occur in separate encounters.
What You Will Learn
- How procedure intent affects skin biopsy reporting
- How malignant lesion removal is distinguished from diagnostic biopsy
- What documentation concepts are relevant when a lesion has already been diagnosed
- How a punch-based skin procedure may be considered in the context of excision versus biopsy
Who Should Read This
- Medical coders
- Billing staff
- Dermatology office staff
- Coding auditors
Codes Discussed
Code Ranges Discussed
- CPT: 116XX
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com